Skip to main content

letter

. 1993 Aug 21;307(6902):500–501. doi: 10.1136/bmj.307.6902.500-c

Serum screening for Down's syndrome. Informed consent is vital...

G Waldron, E S Williams

PMCID: PMC1678745 PMID: 8400944

500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Connor M. Biochemical screening for Down's syndrome. BMJ. 1993 Jun 26;306(6894):1705–1706. doi: 10.1136/bmj.306.6894.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
Marteau T. M. Psychological consequences of screening for Down's syndrome. BMJ. 1993 Jul 17;307(6897):146–147. doi: 10.1136/bmj.307.6897.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
Statham H., Green J. Serum screening for Down's syndrome: some women's experiences. BMJ. 1993 Jul 17;307(6897):174–176. doi: 10.1136/bmj.307.6897.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wald N. J., Kennard A., Densem J. W., Cuckle H. S., Chard T., Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ. 1992 Aug 15;305(6850):391–394. doi: 10.1136/bmj.305.6850.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
Williams E. S., Waldron G. J. Screening, ethics and the law. BMJ. 1992 Dec 5;305(6866):1433–1433. doi: 10.1136/bmj.305.6866.1433-d. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES